This chapter focuses on the epidemiology of pneumococcal disease in terms of pathogen
characteristics and host risk factors. The clinical manifestations of Streptococcus …

Streptococcus pneumoniae causes acute bacterial infections. The bacterium, also called
pneumococcus, was first isolated by Louis Pasteur in 1881 from the saliva of a patient with …

Pneumococcal vaccination : Current Opinion in Infectious Diseases Pneumococcal vaccination
: Current Opinion in Infectious Diseases Log in or Register Subscribe to journalSubscribe Get …

Pneumococcal pneumonia accounts for about one-sixth to two-thirds of all cases of
community-acquired pneumonia. Its high frequency of occurrence worldwide and the high …

The burden of pneumococcal disease among adults in developed countries is neither widely
known nor appreciated. The incidence of pneumococcal pneumonia is uncertain because a …

To overview the present global burden of pneumococcal disease is important because new
preventive measures such as the pneumococcal conjugate vaccine 13 are currently being …

Pneumococcal infections elicited by Streptococcus pneumoniae (pneumococcus)(
pneumonia, otitis media, sinusitis, meningitis) are frequently occurring diseases that are …

Use of the pneumococcal conjugate vaccines among children in the US since 2000 has
dramatically reduced pneumococcal disease burden among adults. Significant vaccine …

Pneumococcal disease, which includes pneumococcal pneumonia, meningitis, and
bacteremia, is associated with substantial morbidity, mortality, and health care costs in …

Pneumococcal vaccine was first licensed in the United States in 1977. During the next two
decades more than 30 million doses of this vaccine were distributed throughout the country …